Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7443 p299
17 March 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Alliance Boots rejects initial £9.7bn takeover approach

Alliance Boots has rejected a £9.7bn takeover approach from US-based KKR private equity group.

Following a board meeting on 12 March, Alliance Boots said of the approach: “The board does not believe it reflects the fundamental value of the company or the attractive prospects, opportunities and synergies available to Alliance Boots following the very recent completion of its merger.”

The approach, which does not constitute a formal take-over bid, is backed by the deputy chairman of Alliance Boots, Stefano Pessina, who already owns 15 per cent of the company. Neither Mr Pessina nor his partner Ornella Barra, who is also an Alliance Boots director, attended the board meeting.

A statement issued late last week by the equity group said: “KKR’s and Stefano Pessina’s objective is to work closely with the existing executive management team to achieve the long-term vision of building a global leader in the health care services and beauty industries.”

KKR is the world’s biggest private equity group. Alliance Boots was formed by merging Boots Group and Alliance UniChem in August 2006.

Stefano Pessina is an Italian who turned a weak family pharmaceutical wholesale business into the successful European wholesaler Alliance Santé. He arranged a reverse take-over of Alliance Santé by UK wholesaler and pharmacy operator UniChem in 1997.

The bid has raised questions over the future of Alliance Boots’s property portfolio, with GMB union official Paul Mahoney predicting an asset stripping exercise.

Back to Top


©The Pharmaceutical Journal